Pharmaceuticals news continually updated from thousands of sources around the net.
4 min ago | JD Supra
Following a series of recent appellate decisions across the spectrum of intellectual property disciplines, including the fields of patent, copyright and trade secrets, the Court of Appeals for the Third Circuit has ruled that a plaintiff cannot rely on a presumption of irreparable harm in seeking preliminary injunctive relief under the Lanham Act.
3 hrs ago | AmericanBankingNews.com
Cardinal Health has been given an average recommendation of "Buy" by the nineteen brokerages that are currently covering the stock, American Banking News.com reports .
7 hrs ago | Wall Street Journal
New Trials Could Help Double the Number of Indications for the Drug, Already Poised to Beat $1 Billion in 2014 Sales Johnson & Johnson and Bayer AG announced plans Friday to launch clinical trials of the anticoagulant Xarelto against three new diseases in an ambitious bid to widen the market for a drug poised to exceed $1 billion in sales this ... (more)
11 hrs ago | Sys-Con Media
Between 2013 and 2014, certain of the Company's officers and directors made statements about the Company's business concerning the sale of digoxin, a drug used for treatment of heart failure.
The expected improvement in availability and affordability of essential medicines as envisaged under the National Pharmaceutical Pricing Policy has been badly vitiated "to a large extent" by the Drug Price Control Order , a study of the pharma industry by the leading business chamber ASSOCHAM has revealed.
Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .
Raptor Pharmaceutical Corp. Director Erich Sager unloaded 10,000 shares of the company's stock on the open market in a transaction that occurred on Monday, August 25th.
Impax Laboratories has received an average rating of "Hold" from the eighteen brokerages that are presently covering the company, Analyst Ratings Network.com reports .
An interferon-free dual combination of Achillion's hepatitis C virus NS5A inhibitor ACH-3012 plus Gilead Science's HCV polymerase inhibitor sofosbuvir taken for 8 weeks led to sustained virological response at 4 weeks post-treatment for people with HCV genotype 1 in a Phase 2 study, according to a company announcement.
"We can't sit still and stay in the U.S. because of all the political rhetoric," said Mylan Inc. CEO Heather Bresch, who helped grow the company from $100 million in revenue to $7 billion in about two decades.
Armetheon, Inc. , a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.
Achillion Pharmaceuticals major shareholder Ra Capital Management, Llc sold 2,112,867 shares of Achillion Pharmaceuticals stock on the open market in a transaction dated Tuesday, August 26th.
Hello, and welcome to the Lannett Company Fiscal 2014 Fourth Quarter and Full Year Financial Results Conference Call.
Mylan is a manufacturer of generic pharmaceuticals. It closed on Tuesday, August 25, 2014 at $48.30.
Teva Pharmaceutical Industries has recalled one lot of its generic Parkinson's disease combination medication carbidopa/levodopa because it may contain too much of an active pharmaceutical ingredient.
The Plan, a first for the industry, was developed by ISPE and its expert pharmaceutical and biopharmaceutical industry members and describes how industry can best prevent drug shortages from occurring by discovering root causes and through creating and sustaining organizational cultures supported by leadership, business processes and quality ... (more)
Venus will collaborate with Teva Pharmaceutical Industries Ltd to develop an anti-cancer drug, it said in a statement on Tuesday.
Updated: Fri Aug 29, 2014 05:33 pm
Copyright © 2014 Topix LLC